Company 10x Genomics, Inc.

Equities

TXG

US88025U1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
37.53 USD +1.73% Intraday chart for 10x Genomics, Inc. -1.24% -32.93%

Business Summary

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Number of employees: 1,259

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumables
77.5 %
436 84.3 % 480 77.5 % +10.09%
Instruments
20.0 %
72 14.0 % 123 20.0 % +70.55%
Services
2.5 %
8 1.6 % 16 2.5 % +86.39%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
58.2 %
285 55.2 % 360 58.2 % +26.35%
Europe, Middle East and Africa
23.0 %
117 22.7 % 142 23.0 % +21.53%
Asia Pacific (excluding China)
8.5 %
46 8.9 % 52 8.5 % +13.67%
China
8.2 %
60 11.5 % 51 8.2 % -14.43%
Americas (excluding United States)
2.1 %
9 1.7 % 13 2.1 % +49.03%

Managers

Managers TitleAgeSince
Founder 47 12-07-01
Founder 49 12-07-01
Director of Finance/CFO 49 18-09-30
Chief Tech/Sci/R&D Officer - 12-12-31
Human Resources Officer - 20-12-31
General Counsel 56 17-06-30

Members of the board

Members of the board TitleAgeSince
Chairman 66 13-07-31
Director/Board Member 65 20-03-25
Director/Board Member 57 17-08-22
Founder 49 12-07-01
Founder 47 12-07-01
Director/Board Member 46 19-02-28
Director/Board Member 52 19-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 14,056,833 0 0 84.78 %
Stock B 1 105,109,711 101,031,768 ( 96.12 %) 0

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
12.16 %
12,785,536 12.16 % 596 M $
Vanguard Fiduciary Trust Co.
8.573 %
9,011,332 8.573 % 420 M $
Baillie Gifford & Co.
7.535 %
7,919,976 7.535 % 369 M $
BlackRock Advisors LLC
5.074 %
5,333,693 5.074 % 249 M $
Eaton Vance Management
3.976 %
4,179,415 3.976 % 195 M $
ARK Investment Management LLC
3.845 %
4,041,287 3.845 % 188 M $
Sands Capital Management LLC
3.416 %
3,590,145 3.416 % 167 M $
Brown Capital Management LLC
3.356 %
3,527,297 3.356 % 165 M $
T. Rowe Price International Ltd.
2.953 %
3,104,174 2.953 % 145 M $
Invesco Advisers, Inc.
2.221 %
2,334,938 2.221 % 109 M $
NameEquities%Valuation
Fidelity Management & Research Co. LLC
28.28 %
5,690,733 28.28 % 265 M $
3,031,865 15.07 % 141 M $
3,000,000 14.91 % 140 M $
2,105,736 10.47 % 98 M $

Company contact information

10X Genomics, Inc.

6230 Stoneridge Mall Road

94588, Pleasanton

+925 401 7300

http://www.10xgenomics.com
address 10x Genomics, Inc.(TXG)